Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
139M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
11M
-
Shares change
-
+394K
-
Total reported value, excl. options
-
$60.9M
-
Value change
-
+$2.12M
-
Number of buys
-
7
-
Number of sells
-
-2
-
Price
-
$5.55
Significant Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) as of Q2 2018
13 filings reported holding XTNT - Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share as of Q2 2018.
Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11M shares
of 139M outstanding shares and own 7.87% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (9.21M shares), Park West Asset Management LLC (1.26M shares), VANGUARD GROUP INC (369K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (50K shares), RENAISSANCE TECHNOLOGIES LLC (43.6K shares), MORGAN STANLEY (10.8K shares), BlackRock Inc. (10.1K shares), UBS Group AG (8.45K shares), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (4.04K shares), and Winslow, Evans & Crocker, Inc. (1.26K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.